Thomas Hoffmann

Serial biotech entrepreneur with 20+ years of experience in starting, growing and selling biotech companies (e.g. Phenex Pharmaceuticals AG acquired by Gilead Science).

A new dawn in the biology
of human reproduction.

Linkedin-in

Explore

Home
About
Science & Product
Contact

Home
About
Science & Product
Contact

Our Office

dawn-bio GmbH, Dr.-Bohr-Gasse 7, 1030 Vienna, Austria, FN 596389 v

hello@dawn-bio.com

© 2025 Consequence. All rights reserved.

Manage Consent

Our website use cookies. By continuing navigating, we assume your permission to deploy cookies as detailed in our Privacy Policy.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

View preferences

{title} {title} {title}

Thomas Hoffmann

Explore

Featured Links

Our Office

© 2025 Consequence. All rights reserved.